The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
The intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. During the sessions, participants will learn techniques for managing and changing nightmares.
University of Utah
Salt Lake City, Utah, United States
RECRUITINGDisturbing Dream and Nightmare Severity Index (DDNSI)
The DDNSI is a questionnaire which measures the severity of nightmares.
Time frame: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)
Nightmare frequency (sleep diary)
The number of nightmares experienced each day will be collected on daily sleep diaries completed during each assessment period.
Time frame: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)
PROMIS Anxiety
Questionnaire which measures the severity of anxiety symptoms.
Time frame: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)
PROMIS Depression
Questionnaire which measures the severity of depressive symptoms.
Time frame: Completed at each of the three assessments (baseline, 10 weeks, 19 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.